<SEC-DOCUMENT>0001193125-22-176598.txt : 20220617
<SEC-HEADER>0001193125-22-176598.hdr.sgml : 20220617
<ACCEPTANCE-DATETIME>20220617165201
ACCESSION NUMBER:		0001193125-22-176598
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220617
DATE AS OF CHANGE:		20220617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		221024664

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d727055ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. ) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by
<FONT STYLE="white-space:nowrap">Rule&nbsp;14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under <FONT STYLE="white-space:nowrap">&#167;&nbsp;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>AMARIN CORPORATION PLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s)
Filing Proxy Statement, if other than the Registrant) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Rules&nbsp;14a-6(i)(1)&nbsp;and&nbsp;0-11</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g727055g0618004723132.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>77 Sir John Rogerson&#146;s Quay, Block C </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Grand Canal Docklands, Dublin 2, Ireland </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Registered in England&nbsp;&amp; Wales under Company No.&nbsp;2353920) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPLEMENT TO THE PROXY STATEMENT FOR THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON JUNE&nbsp;27, 2022 AT 3:00 P.M. (LOCAL DUBLIN TIME) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of this supplement to the proxy statement of Amarin Corporation plc, filed with the Securities and Exchange Commission on May&nbsp;24, 2022 (the
&#147;<U>Proxy Statement</U>&#148;), relating to our 2022 Annual General Meeting of Shareholders to be held on June&nbsp;27, 2022 (the &#147;<U>2022 Annual General Meeting</U>&#148;) is to clarify potential misunderstanding we have identified as to
the wording and certain inconsistency of language in the Proxy Statement. For the sake of absolute clarity, in light of inconsistent statements in the Proxy Statement concerning voting standards for &#147;ordinary resolutions,&#148; note that
abstentions will have no effect on the vote outcome of any such ordinary proposals at the 2022 Annual General Meeting, including Proposal 7 regarding the adoption of an amendment to the Company&#146;s 2020 Stock Incentive Plan (the &#147;<U>Plan
Amendment</U>&#148;). This supplement therefore only applies to and clarifies the description of the voting standard applicable to Proposal 7, as incorrectly described on pages 4 and 21 of the Proxy Statement. Consistent with the Companies Act, our
Articles of Association and our usual tabulation practices, the outcome for all ordinary resolutions will be determined by a majority of votes cast and such outcomes will therefore not be impacted by any abstentions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, the first full paragraph on page 4 is updated as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Proposal No. 7&#151;Approval of an amendment to the Company&#146;s 2020 Stock Incentive Plan. </I>This proposal will be approved if (i)&nbsp;on a show
of hands, a majority of shareholders present in person or by proxy and voting on the proposal vote in favor of the resolution or (ii)&nbsp;on a poll, a majority of the shares present at the meeting in person or by proxy and voting on the proposal
are voted in favor of the resolution. As a result, abstentions and <FONT STYLE="white-space:nowrap">broker&nbsp;non-votes&nbsp;will</FONT> have no effect on the vote outcome.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the paragraph under the heading &#147;Vote Required&#148; on page 21 is updated as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This proposal will be approved if (i)&nbsp;on a show of hands, a majority of shareholders present in person or by proxy and voting on the proposal vote
in favor of the resolution or (ii)&nbsp;on a poll, a majority of the shares present at the meeting in person or by proxy and voting on the proposal are voted in favor of the resolution. As a result, abstentions and
<FONT STYLE="white-space:nowrap">broker&nbsp;non-votes&nbsp;will</FONT> have no effect on the vote outcome.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted elsewhere in the Proxy
Statement and consistent with the Companies Act and our Articles of Association, the standard for approval of an ordinary resolution is a majority of the votes cast, and, under the Companies Act and our Articles of Association, abstentions are not
considered votes cast. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This supplement is being filed to confirm the voting standard as described above, including that abstentions will
<B><U>not</U></B> have the same effect as voting AGAINST Proposal 7 for approval of the Plan Amendment, which was unclear due to a scrivener&#146;s error identified by management and our proxy solicitor while reviewing vote tabulations to date in
the unmodified version of the Proxy Statement.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We issue this supplement to clarify and avoid any confusion and investors should contact our proxy
solicitor, Okapi Partners LLC, at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-844-343-2625</FONT></FONT></FONT> with any inquiries regarding this supplement or otherwise in connection with the
2022 Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of these clarifications, the Instruction Date for instructions from the ADS holders has been extended such that
instructions must be sent to the Depositary so that the instructions are received by no later than 10:00 a.m. New York time on June&nbsp;22, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
supplement should be read in conjunction with the Proxy Statement, and does not change the proposals to be acted upon at the 2022 Annual General Meeting, which are described in the Proxy Statement, or the other information in the Proxy Statement.
Defined terms used but not defined herein are as defined in the Proxy Statement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this supplement to the proxy statement is
June&nbsp;17, 2022 </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g727055g0618004723132.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g727055g0618004723132.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D + # 2(  A$! Q$!_\0
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ML4A5@ J&X4A5&>,\=!WKRGXW^#/^$:\8MJ-M&%T_52TR #A).-Z_F<_C[5]
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CPYIOAKXX:W;Z5#Y%O<:0MP8@?E1FE (4=AQT[9]*** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
